Moderna Inc. (NASDAQ:MRNA) reported a third-quarter loss of 51 cents, beating the expected loss of $2.02, a turnaround from an income of 3 cents a year ago.MRNA stock is racing ahead of the pack. Get the complete analysis hereThe COVID-19 vaccine maker reported quarterly sales of $1.02 billion, topping the expected $886.54 million.Sales declined 45% to $1.9 billion from a year ago, primarily due to a $847 million, or 47%, decrease in net product sales, as COVID vaccine sales decreased.In the U.S., lower sal ...